MH, Y., PH, C., M, P. M., H, N., NTT, T., SM, F., & BB, A. (2026). Strain diversity drives heterogeneous responses to tuberculosis combination therapy. Antimicrobial agents and chemotherapy, 70(6), e0184925. https://doi.org/10.1128/aac.01849-25
Chicago Style (17th ed.) CitationMH, Yoon, Culviner PH, Pereira Moraes M, Nitta H, Thuong NTT, Fortune SM, and Aldridge BB. "Strain Diversity Drives Heterogeneous Responses to Tuberculosis Combination Therapy." Antimicrobial Agents and Chemotherapy 70, no. 6 (2026): e0184925. https://doi.org/10.1128/aac.01849-25.
MLA (9th ed.) CitationMH, Yoon, et al. "Strain Diversity Drives Heterogeneous Responses to Tuberculosis Combination Therapy." Antimicrobial Agents and Chemotherapy, vol. 70, no. 6, 2026, p. e0184925, https://doi.org/10.1128/aac.01849-25.